» Articles » PMID: 30341423

Pyroptosis Versus Necroptosis: Similarities, Differences, and Crosstalk

Overview
Specialty Cell Biology
Date 2018 Oct 21
PMID 30341423
Citations 491
Authors
Affiliations
Soon will be listed here.
Abstract

Pyroptosis and necroptosis represent two pathways of genetically encoded necrotic cell death. Although these cell death programmes can protect the host against microbial pathogens, their dysregulation has been implicated in a variety of autoimmune and auto-inflammatory conditions. The disease-promoting potential of necroptosis and pyroptosis is likely a consequence of their ability to induce a lytic cell death. This cell suicide mechanism, distinct from apoptosis, allows the release of immunogenic cellular content, including damage-associated molecular patterns (DAMPs), and inflammatory cytokines such as interleukin-1β (IL-1β), to trigger inflammation. In this Review, we discuss recent discoveries that have advanced our understanding on the primary functions of pyroptosis and necroptosis, including evidence for the specific cytokines and DAMPs responsible for driving inflammation. We compare the similar and unique aspects of pyroptotic- and necroptotic-induced membrane damage, and explore how these may functionally impact distinct intracellular organelles and signalling pathways. We also examine studies highlighting the crosstalk that can occur between necroptosis and pyroptosis signalling, and evidence supporting the physiological significance of this convergence. Ultimately, a better understanding of the similarities, unique aspects and crosstalk of pyroptosis and necroptosis will inform as to how these cell death pathways might be manipulated for therapeutic benefit.

Citing Articles

The Novel H10N3 Avian Influenza Virus Triggers Lethal Cytokine Storm by Activating Multiple Forms of Programmed Cell Death in Mammalian Lungs.

Wang X, Wang X, Hao X, Gao R, Lu X, Yang W Int J Mol Sci. 2025; 26(5).

PMID: 40076601 PMC: 11899735. DOI: 10.3390/ijms26051977.


From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases - Opportunity or Challenge?.

Fang J, Zhu W, Yu D, Zhu L, Zha H, Tang J J Inflamm Res. 2025; 18:3349-3360.

PMID: 40070928 PMC: 11895680. DOI: 10.2147/JIR.S498703.


SNS‑032 combined with decitabine induces caspase‑3/gasdermin E‑dependent pyroptosis in breast cancer cells.

Chen Y, Zhang D, Li J, Sun Y, Wang J, Xi L Oncol Lett. 2025; 29(4):202.

PMID: 40070781 PMC: 11894506. DOI: 10.3892/ol.2025.14948.


Different types of cell death and their interactions in myocardial ischemia-reperfusion injury.

Du B, Fu Q, Yang Q, Yang Y, Li R, Yang X Cell Death Discov. 2025; 11(1):87.

PMID: 40044643 PMC: 11883039. DOI: 10.1038/s41420-025-02372-5.


COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case-Control Study.

DAmico R, Nagashima S, Carstens L, Bertoldi K, Mataruco S, Honorio DAgostini J Int J Mol Sci. 2025; 26(4).

PMID: 40004007 PMC: 11855377. DOI: 10.3390/ijms26041541.


References
1.
Karasawa T, Takahashi M . Role of NLRP3 Inflammasomes in Atherosclerosis. J Atheroscler Thromb. 2017; 24(5):443-451. PMC: 5429158. DOI: 10.5551/jat.RV17001. View

2.
Conos S, Chen K, De Nardo D, Hara H, Whitehead L, Nunez G . Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci U S A. 2017; 114(6):E961-E969. PMC: 5307433. DOI: 10.1073/pnas.1613305114. View

3.
Weinlich R, Oberst A, Beere H, Green D . Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2016; 18(2):127-136. DOI: 10.1038/nrm.2016.149. View

4.
Bakker P, Butter L, Claessen N, Teske G, Sutterwala F, Florquin S . A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion. Am J Pathol. 2014; 184(7):2013-22. PMC: 5707188. DOI: 10.1016/j.ajpath.2014.04.005. View

5.
Wang H, Sun L, Su L, Rizo J, Liu L, Wang L . Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014; 54(1):133-146. DOI: 10.1016/j.molcel.2014.03.003. View